期刊文献+

胰岛素强化治疗对脓毒症预后及血清炎症介质水平的影响 被引量:3

Effect of intensive insulin therapy on prognosis and serum inflammatory cytokine levels in patients with sepsis
下载PDF
导出
摘要 目的研究胰岛素强化治疗对脓毒症患者预后及血清炎症介质的影响,探讨其可能的机制。方法将40例脓毒症患者随机配对分成胰岛素强化治疗组(n=20)和常规治疗组(n=20)。于入院后采用酶联免疫吸附法(EL ISA)连续检测血清肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)及白细胞介素-10(IL-10)水平,并监测C反应蛋白(CRP)变化。同时记录两组呼吸机使用天数、抗生素使用天数、ICU住院天数、病死率及多器官功能障碍综合征(M ODS)的发生率。结果胰岛素强化治疗组呼吸机与抗生素使用天数、ICU住院天数、病死率、M ODS的发生率均低于常规治疗组。且TNFα-、IL-6、CRP IL-10水平各组均存在时间效应。结论胰岛素强化治疗可改善脓毒症病情,降低病死率,其机制除降血糖、促进合成代谢作用外还可能与其抗炎效应相关。 Objective To investigate the effect of intensive insulin therapy on prognosis and serum inflammatory cytokine levels in patients with sepsis, and to explore the potential mechanism of the intensive insulin therapy. Methods Forty patients with sepsis were randomly divided into intensive insulin therapy group (n= 20) and control group (n = 20). Enzyme-linked immunoadsorbent assay (ELISA) was used to determine the serum levels of tumor necrosis factor-α(TNF-α) ,interleukin-6(IL-6),interleukin-10(IL-10) and C reaction protein(CRP) after admission. The days of using mechanical ventilation, using antibiotic, and in ICU, mortality and the rats of multiple organ dysfunction syndrome (MODS) were measured during the study. Results The days of using mechanical ventilation and antibiotic, the days in ICU, mortality and the rats of MODS in patients of the intensive insulin therapy group were decreased significantly than those in the control group (P〈0. 05). Serum levels of TNF-α, IL-6, and CRP in patients receiving intensive insulin therapy were significantly lower than those in patients without the therapy (P〈0.05 orP〈0. 01),but the levels of IL-10 in patients of the intensive insulin therapy group were higher than those in the control group(P〈0.05). Conclusion Intensive insulin therapy can improve the effect and decrease mortality of the patients with sepsis. The antiinflammatory actions of insulin, as well as its glycemia-controlling effects, might favorably contribute to the prognosis of patients with sepsis.
出处 《西部医学》 2007年第3期392-394,共3页 Medical Journal of West China
关键词 脓毒症 胰岛素强化治疗 细胞因子 Sepsis Intensive insulin therapy Cytokine
  • 相关文献

参考文献2

二级参考文献15

  • 1Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care.Crit Care Med, 2001,29:1303-1310.
  • 2Zeni F,Freeman BF,Natanson C.Anti inflammatory therapies to treatsepsis and septic shock:areassessment.Crit Care Med,1997,25:1095-1100.
  • 3Bone RC,Balk RA,Cerra FB,et al.Definations for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Chest,1992,101:1644-1655.
  • 4Warren HS.Strategies for the treatment of sepsis.N Engl J Med, 1997,336:952-953.
  • 5Hotchkiss RS,Karl IE.The pathophysiology and treatment of sepsis.N Engl J Med,2003,348:138-150.
  • 6Rivers E,Nguyen B,Havstad S,et al.Early goal-directed therapy in thetreatment of severe sepsis shock.N Engl J Med,2001,345:1368-1377.
  • 7Choi PT,Yip G,Quinonez LG,et al.Crystalloids vs colloid in fluid resuscitation:a systematic review.Crit Care Med,1999,27:200-210.
  • 8Bellomo R,Chapman M,Finfer S,et al.Low-dose dopamine in patients with early renal dysfunction:a placebo-controlled randomized trial.Lancet,2000,356:2139-2143.
  • 9Martin C,Vincent JL,Laterre PF,et al.Effect of norepinephrine on the outcome of septic shock.Crit Care Med,2000,28:2785-2765.
  • 10Annane D. Corticosteroids for septic shock. Crit Care Med, 2001,29(suppl):s117-s120.

共引文献25

同被引文献43

  • 1樊寻梅.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中华儿科杂志,2006,44(8):596-598. 被引量:205
  • 2骆建军,方强,方雪玲,戚晓平,周博武.脓毒症患者肠道黏膜通透性的临床研究[J].中国急救医学,2007,27(9):789-792. 被引量:13
  • 3Shapiro N, Howell MD, Bales DW, et al. The association of sepsis syndrome and organ dysfunction with mortality in emergency depart- ment patients with suspected in fection[ J]. Ann Emerg Med, 2006, 48 (5) : 583-590.
  • 4Hirseh IB, Coviello A, Mazuski J, et al. Intensivinsul in therapy in critically ill patients[J]. N Engl J Med, 2002, 346(120) : 1586- 1588.
  • 5Barkhansen T, Probst C, Hildebrand F, et al. Insulin therapy in- duces changes in the inflammatory response in a murine 2-hitmodel [J].Injury, 2009, 40(8): 806-814.
  • 6Antonopoulou A, Giamarellos-Bourboulis EJ. Immunomodula- tion in sepsis state of the art an d future perspectiveEJ. Immu- notherapy, 2011, 3(1): 117-128.
  • 7Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/AC- CP/ATS/SIS international sepsis definitions conference J. Intens Care Med, 2001, 29(4): 530-538.
  • 8Hirsch IB, Coviello A, Mazuski J, et al. Intensive insulin in therapy in critically ill patientsLJ]. N Engl J Med, 2002, 346 (120) 1586-1588.
  • 9Stacey L, Bateman, Patrick CS. Procession to pediatric bacte- remia and sepsis., covert operations and failures in diplomacy EJ]- Pediatrics, 2010, 126(2) 137-150.
  • 10Barkhausen T, Probst C, Hildebrand F, et al. Insulin therapy induces changes in the inflammatory response in a routine 2-hit modelEJ. Injury, 2009, 40(8): 806-814.

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部